Press release
Polycystic Kidney Disease Therapeutics - Key Players Analysis Otsuka Pharmaceutical Companies (U.S.), Exelixis, XORTX Pharma Corp
PKD affects kidney along with other organs, in which development of cyst interrupts the ability to filter the waste products from blood. The disease is mostly related to high blood pressure, blood in urine, pain in back, kidney stones and heart valve abnormalities. Enlargement of cyst may lead to kidney failure which can in turn impact other organs. People with PKD are at a risk of developing aneurysm in aorta or in blood vessels in base of the brain. The disease can be categorized into two types, as autosomal dominant polycystic kidney disease (AKPKD), and autosomal recessive polycystic kidney disease (ARPKD). AKPKD generally diagnosed in adulthood, while ARPKD diagnosed in earliest months of life.
Download report sample at: https://www.psmarketresearch.com/market-analysis/polycystic-kidney-disease-therapeutics-pipeline-analysis/report-sample
*Increased Funding by the Government Organizations Contributing Immensely in Pipeline Growth
Novatarg Pharmaceuticals, received $3.2 million funding by Small Business Innovation Research (SBIR), a part of governmental agencies of National Institutes of Health, to further conduct clinical study in PKD. Novatarg Pharmaceuticals, is in the process of research and development activities of NT 1044. Through the funding, NovaTarg Pharmaceuticals had further planned to progress drug candidates for PKD and type II diabetes mellitus. In addition, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is also supporting the pharmaceutical companies to conduct clinical study and research on PKD to improve patient health.
Pre_Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=polycystic-kidney-disease-therapeutics-pipeline-analysis
Some of the key players developing drugs for the treatment of PKD therapeutics include Otsuka Pharmaceutical Co., Ltd., Exelixis, Inc., and XORTX Pharma Corp.
*Surge in the development of Pre-Clinical and Discovery Drug Candidates
Many pharmaceutical companies are involved in the development of therapeutic compounds by overcoming the challenges, that are effective in the treatment of PKD. They are focusing on developing the maximum drug candidates in the Pre-Clinical and Discovery stage of development. The pipeline consists of approximately eight drug candidates in the Pre-Clinical stage. GLG Pharma is in the process of developing two drug candidates in Pre-Clinical stage.
Browse report at: https://www.psmarketresearch.com/market-analysis/polycystic-kidney-disease-therapeutics-pipeline-analysis
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Polycystic Kidney Disease Therapeutics - Key Players Analysis Otsuka Pharmaceutical Companies (U.S.), Exelixis, XORTX Pharma Corp here
News-ID: 1417047 • Views: …
More Releases from P&S Intelligence
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media.
In order to pace up the 4th industrial revolution, businesses across various industries…
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG.
North America will grow the fastest with a rate of 10.5% in…
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use.
Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls…
North America, the Largest Revenue Producer in Public Safety and Security Market
The size of the public safety and security market was at $411 billion in the year 2021, which will reach over $1,115 billion by the year 2030, advancing at a growth rate of around 12% in the years to come. This is largely ascribed to the rising application of innovative technologies in smart cities, increasing crime rates, the increasing cases of disastrous accidents, and the growing count of terrorist activities…
More Releases for PKD
Global Polycystic Kidney Disease (PKD) Market Analysis, Scope and Forecast By 20 …
Polycystic kidney disease (PKD) is essential for a heterogeneous gathering of issues described by renal blisters and various foundational and extrarenal signs. The market forecast by Infinity Business Insights centers around the market income produced by the pharmacological treatment which are essentially indicative or palliative in nature. Antihypertensive medications to slow the weakening of Renal Function, Antibiotics to treat UTI or contaminated renal sores and Analgesics to control renal torment.
Coronavirus…
Oilfield Equipment Rental Market to 2027 - Global Analysis and Forecasts by Top …
The oil and gas industries use oilfield equipment rental services for well test and well clean-up operations. The demand for these equipment rentals is skyrocketing with the increase in global investments for exploration and production. The unconventional hydrocarbon production in the North American region is sighted as a key driver for the immense growth of the oilfield equipment rental market in this region. Additionally, the area also witnesses excessive exploration…
PKD Therapeutics Pipeline Analysis by Phase, Molecule Type, Route of Administrat …
Polycystic kidney disease (PKD) is a genetic disorder that primarily affects kidneys. It causes fluid-filled cysts to grow inside the kidneys, which increase the size and damage tissues of the kidneys. Symptoms of the disease include abdomen and back pain, urinary tract infection, frequent urination, blood in urine, kidney stones, and others. There are mainly two types of PKD: autosomal dominant PKD (ADPKD) and autosomal recessive PKD (ARPKD). The main…
Polycystic Kidney Disease Treatment Market Segments And Key Trends 2018-2028
Polycystic kidney disease (PKD) is an inherited kidney disorder in which fluid-filled cysts (noncancerous round sacs containing fluid) are developed within the kidneys. PKD may impair kidney function and eventually cause kidney failure. This disease can cause serious complications, including high blood pressure and kidney failure, and sometimes may lead to liver and other complications. PKD is said to be the fourth leading cause of kidney failure.
There are three types…
Polycystic Kidney Disease Treatment Market: Future Forecast Indicates Impressive …
Polycystic kidney disease (PKD) is an inherited kidney disorder in which fluid-filled cysts (noncancerous round sacs containing fluid) are developed within the kidneys. PKD may impair kidney function and eventually cause kidney failure. This disease can cause serious complications, including high blood pressure and kidney failure, and sometimes may lead to liver and other complications. PKD is said to be the fourth leading cause of kidney failure.
There are three types…
Polycystic Kidney Disease Therapeutics Pipeline Analysis- Clinical Trials & Resu …
The study analyzed that the polycystic kidney disease (PKD) therapeutics pipeline comprises approximately 16 drug candidates in different stages of development. PKD affects kidney along with other organs, in which development of cyst interrupts the ability to filter the waste products from blood. The disease is mostly related to high blood pressure, blood in urine, pain in back, kidney stones and heart valve abnormalities.
Enlargement of cyst may lead to…
